Heart Health Symposium 2014
13 – 15 February 2014
Düsseldorf, Germany
HHS Bayer tarafından her yıl düzenlenen; hipertansiyon, diyabet, Pulmoner Arteriyel
Hipertansiyon (PAH) ve arteriyel-venöz trombotik hastalıklar gibi kardiyovasküler
hastalıkların ve güncel tedavi yöntemlerinin tartışılacağı, bilimsel bir toplantıdır. Bu
toplantıda farklı ülkelerden ve ülkemizden hekimler konuşmacı olarak yeralacak ve
kardiyovasküler hastalıklar konusunda deneyim paylaşımında bulunacaklardır.
Wednesday, 12 February 2014
Swissôtel, Neuss/Düsseldorf, Germany
Arrival
20:00
Buffett Dinner at the Hotel
Thursday, 13 February 2014
BayKomm, Leverkusen, Germany
07:45
09:00
Transfer to Baykomm Exhibition Centre in Leverkusen,
Germany
Welcome Speech by Chairman
09:05
Bayer’s Competence in Cardiology
09:30
The Role of CCB’s in Hypertension - Future Treatment
Strategies
10:30
Coffee Break
11:00
The Importance of Managing Postprandial Blood Glucose Oliver Schnell,
in Diabetic Patients for Cardiovascular Outcomes
Germany
12:00
12:45
“Diabesity” – Effects of long-term Testosterone
Treatment on Obesity and Type 2 Diabetes
Lunch at Bayer Kasino
14:00
Baykomm Exhibition Centre Visit + Production Site Visit
17:30
20:00
Transfer back to the Hotel
Dinner
Frank Eitner,
Germany
Frank Eitner,
Germany
Hermann
Haller,
Germany
Farid Saad,
Germany
Friday, 14 February 2014
Swissôtel, Neuss/Düsseldorf, Germany
09:00
Welcome Speech by Chairman
09:05
10:30
Thrombosis Management: Xarelto® - One Oral
Anticoagulant for 5 Indications
The Challenge of Stroke Prevention in AF Patients.
Practical Management of New Oral Anticoagulants
Coffee Break + Meet-the-Expert Session
11:00
Treatment of VTE: Can we offer a Single-Drug Approach?
11:45
Establishing a new Standard of Care in PE Treatment
12:30
Lunch
14:00
From acute PE to CTEPH
14:45
CTEPH - disease management
15:30
Coffee Break
16:00
Meet-the-Expert Session with Patient Case Discussions
09:30
Journey from PE to CTEPH
Surgical Treatment of CTEPH
17:30
Closing Remarks
19:30
Dinner
Alexander
Cohen, UK
Alexander
Cohen, UK
Ilke Siphai,
Turkey
Alexander
Cohen, UK &
Ilke Siphai,
Turkey
Alexander
Cohen, UK
Aris
Exadaktylos,
Switzerland
Marion
Delcroix,
Belgium
Adam Torbicki,
Poland
Marion
Delcroix,
Belgium &
Adam Torbicki,
Poland
Pınar Önen,
Turkey
Bedrettin
Yıldızeli,
Turkey
Saturday, 15 February 2014
Swissôtel, Neuss/Düsseldorf, Germany
09:00
Welcome Speech by Chairman
09:05
SimCase 1
Instructors:
Öner Özdoğan
Fehmi Mercanoğlu
Harun Koca
Mustafa Tunç Solak
Filiz Akyildiz Akcay
Tunay Sentürk
Aspirin Prophylaxis: The Reduction of Vascular Disease
and Beyond
Coffee Break
09:40
10:30
11:00
11:30
12:15
SimCase 2
Instructors:
Kamil Tülüce
Levent Özdemir
Davran Ciçek
Ali Boyaci
Dilek Ergün
Ufuk Eryilmaz
Anticoagulants in ACS: The Key to Optimizing
Combination Therapy in Secondary Prevention
13:00
Defining the right Patient for ACS Treatment with
Rivaroxaban
Closing Remarks
13:15
Lunch and Departure
Freek W.A.
Verheugt,
Netherlands
Fabio
Tarantino &
Peter Elwood,
UK
Peter Elwood,
UK
Fabio
Tarantino &
Andreas Zirlik,
Gemany
Freek W.A.
Verheugt,
Netherlands
Andreas Zirlik,
Gemany
Download

Heart Health Symposium 2014